Relevance of ucc-research-protocol-foldbench-antibody-antigen to "Which predicted interfaces or structures are reliable enough to guide my next experiment?"
- Use case
- Choose structural hypotheses to guide experiments
- Assessed by
- FoldBench antibody-antigen published full-set assessment
- Relevance
- Proxy evidence
- Endpoint
- FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries
The only multi-tool comparison stored for antibody-antigen complexes on a held-out set with five current cofolding tools under one protocol. It is proxy evidence: success means structural agreement with the deposited complex, and confidence is not assessed.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
40 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations2 values
| Benchmarking all-atom biomolecular structure prediction with FoldBench ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Citation locations2 values
| FoldBench supplementary target coverage and performance ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison group antibody-antigen-interfaces Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison group antibody-antigen-interfaces Context-only references | FoldBench supplementary target coverage and performance ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison title Antibody-antigen interface predictions Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison title Antibody-antigen interface predictions Context-only references | FoldBench supplementary target coverage and performance ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints4 values
| Benchmarking all-atom biomolecular structure prediction with FoldBench ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints4 values
| FoldBench supplementary target coverage and performance ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries Context-only references | FoldBench supplementary target coverage and performance ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- Benchmarking all-atom biomolecular structure prediction with FoldBench · Original source · 10.1038/s41467-025-67127-3
- FoldBench supplementary target coverage and performance · Original source · Supplementary Information to 10.1038/s41467-025-67127-3
Technical metadata and extraction receipts
Stable ID: use-case-mapping-structural-20261009-foldbench-antibody-antigen
- field
- links:assessed_by:ucc-research-protocol-foldbench-antibody-antigen
- value
- ucc-research-protocol-foldbench-antibody-antigen
- relevance
- proxy
- endpoint
- FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries
- rationale
- The only multi-tool comparison stored for antibody-antigen complexes on a held-out set with five current cofolding tools under one protocol. It is proxy evidence: success means structural agreement with the deposited complex, and confidence is not assessed.
- constraints
- Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; complex sets, sampling and metrics differ.; Results for one complex class do not establish performance in another.; Structural accuracy and confidence are not evidence that an interaction exists, how strong it is or that an experiment will work.
- limitations
- Benchmark authors ran all five tools; per-tool assessable counts differ, so the scored populations are not matched.; Structural success against the deposited complex, not binding, affinity or the outcome of an experiment.; No uncertainty is printed.; Antibody-antigen targets only.; The mapped evaluations are stored records reviewed in an earlier batch; this review checked their status, their links and their fit, not their values against FoldBench.
- citation locators
- source id: ucc-research-source-foldbench-supp; locator: Supplementary Table 3, antibody-antigen block; source id: ucc-research-source-foldbench-paper; locator: Table 1 assessable counts
- source locator
- ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts
- revision
- 1
- reason
- Add comparisons of structure-prediction reliability by complex class from the structural hypotheses use-case pass 2026-10-09.
- comparison group
- antibody-antigen-interfaces
- comparison title
- Antibody-antigen interface predictions
- headline metric
- foldbench-success-rate
- stratum label
- Accuracy of five tools (FoldBench)
- stratum order
- 1
- reviewed evaluations
- ucc-research-eval-foldbench-antibody-antigen-af3; ucc-research-eval-foldbench-antibody-antigen-boltz1; ucc-research-eval-foldbench-antibody-antigen-chai1; ucc-research-eval-foldbench-antibody-antigen-helixfold3; ucc-research-eval-foldbench-antibody-antigen-protenix
- review
- method: automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; reviewed at: 2026-10-10T00:30:00Z; note: Independent review of endpoint fit, relevance grade, limitations, exclusions and grouping against the use case. The mapped evaluations and their results are already source_checked in the store and were not re-extracted here; their FoldBench values were reviewed in the batch that added them. No execution, reproduction, human scientific review or clinical validation.
- pins
- record id: ucc-research-eval-foldbench-antibody-antigen-af3; fields: status; links; attributes.origin; attributes.comparison; sha256: 54d2bed125c2af8cea77efb5c9d2531423622beace308b59c0b86c0ae619e60b; record id: ucc-research-eval-foldbench-antibody-antigen-boltz1; fields: status; links; attributes.origin; attributes.comparison; sha256: 3ba375ca1ffb0e5286d5b2f31a89e21388c8bad4675bb567963820dcbeaa2e8d; record id: ucc-research-eval-foldbench-antibody-antigen-chai1; fields: status; links; attributes.origin; attributes.comparison; sha256: 91917466e3b1c209230c815382bafd238c85b72bcdcd0495ad642085aeaa0da2; record id: ucc-research-eval-foldbench-antibody-antigen-helixfold3; fields: status; links; attributes.origin; attributes.comparison; sha256: 9d4eaa21a5cd25a2d51f52a3c334ba298cbe46e019222f4d8e5b6adb6720e2ba; record id: ucc-research-eval-foldbench-antibody-antigen-protenix; fields: status; links; attributes.origin; attributes.comparison; sha256: f5d37644b7d53ac4ef5b713d50a40ba35bc66dc647df12f3ea5b5a507cb0cbea; record id: ucc-research-protocol-foldbench-antibody-antigen; fields: status; name; description; facets; source_ids; links; attributes; sha256: 91a123584b1c7f25c9f447435c0e87bef7fe365fe4e68be1410c8f9f4aef2a97; record id: ucc-research-result-foldbench-antibody-antigen-af3-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d4c3da6fe3d5aea2f2387e4eb31c20286ab1cf8f310b20a833cafc36f5a01b0e; record id: ucc-research-result-foldbench-antibody-antigen-af3-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 1815a7850b084d619237261e32c3c6d1d40b21c25f9d1e2c0ab4ec9668b10e7e; record id: ucc-research-result-foldbench-antibody-antigen-af3-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: b67235e6a720e20fcc86405f3ec953e380e224725974a0f8fbe4c6e51ab7416d; record id: ucc-research-result-foldbench-antibody-antigen-af3-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 98b37dd98221d934f93be13514d8ca59c22ccf44dbe67e258ac3aff34ac73d2c; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: cb2dc2ecb32bb570697b5b9a291d775c00834cbcf3c16d285d44024f901b3512; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3e16f64f4f094f989f39fc8ed53b06ac1094da0a2d9b43bc557c0328a06f736d; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8e1653045021358ced401d1bdab5d8387a180899476a5434db8f49e9e111f028; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: da13210c68200f578dbe5625ecefc4e7b8eff0c837119a4135012c24aee9de91; record id: ucc-research-result-foldbench-antibody-antigen-chai1-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: f6df3023c26d4c2f7b178d12bf3b13e5cb6ff1029c2d59124b003fef30ab0320; record id: ucc-research-result-foldbench-antibody-antigen-chai1-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d769e4809a3bf5af504b1d5874caf550af637cdc89093786d21f0754c8b20288; record id: ucc-research-result-foldbench-antibody-antigen-chai1-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8dd92674d074c7240be4dd42c7c7123487e2b9d51c61a9f42df6f5cbf6cec9d1; record id: ucc-research-result-foldbench-antibody-antigen-chai1-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9cb873e508c6b96a7e2d474774b1b2094f2e7ffbbe27f05b4091297e06686889; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: aa52c743c0f011ffb11a9ab2f43cb17870ef881296add0843e4fb5a4921ed80d; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3e16f64f4f094f989f39fc8ed53b06ac1094da0a2d9b43bc557c0328a06f736d; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8cc5f117edf2dd514a3f4697b7ae7d513a3727c46310bf08447a533036e1e8be; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: aef895a81e9f64dc83e0c9fcf1b6bae0d0b608793b586a3143a396c8dc66c6de; record id: ucc-research-result-foldbench-antibody-antigen-protenix-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 7e99b58fe7541fb4dbe721c7db5c53a2dc2b8c0e8bf03a218075b07195d66215; record id: ucc-research-result-foldbench-antibody-antigen-protenix-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d769e4809a3bf5af504b1d5874caf550af637cdc89093786d21f0754c8b20288; record id: ucc-research-result-foldbench-antibody-antigen-protenix-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 65a617cbb7b631e8e1e8660713c7dd9585e8d7c0078df17fc662c8f9ea2b42ef; record id: ucc-research-result-foldbench-antibody-antigen-protenix-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 675b91a6ddf32cf262c3cb2778df71c984dfb014f679c195edd65837989d6f4e; record id: ucc-research-source-foldbench-code; fields: status; attributes.artifact_sha256; sha256: b97ab3e3cd7f20ced10d92de2e33fdb7f3beb8e3b3f107101ecfdb289eb7b60c; record id: ucc-research-source-foldbench-paper; fields: status; attributes.artifact_sha256; sha256: 5223745a7869c987d6285239b14b39e9673f01a9e4f51721ee51bb3573bd2c0d; record id: ucc-research-source-foldbench-supp; fields: status; attributes.artifact_sha256; sha256: 676f28c7775d7f6a7ca7fc28f4407a8a13fd6f6d7854d7743cec93dc082d72b1; record id: use-case-structural-hypotheses-experiments; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 323c287cae7885e983feb5d58f24115afe49ecfbb868a0238c75b1247ffcf228